Dating back to the seminal 1954 polio vaccine trial involving 1.8 million U.S. children , randomized, controlled trials have generated the gold-standard evidence for making public health recommendations [2,3]. I repeat “recommendations,” not “mandates.”
There are no data from four decades of influenza vaccine randomized, controlled trials, and < 2-years of covid-19 vaccine randomized, controlled trials, that either influenza or covid-19 vaccines reduced viral transmission within any randomized, controlled trial design. [4-8] Indeed, none of these influenza or covid-19 vaccine randomized, controlled trials even attempted mass contact tracing of trial participants to establish a legitimate claim for reduced community transmission. Given such deficient data, recommending mass influenza or covid-19 vaccination is at best inappropriate; mandating either practice based upon the evidence-devoid claim of “reduced community viral transmission,” is coercive, anti-scientific, neo-Soviet Lysenkoism.
Moreover, regarding covid-19, we now have voluminous evidence from covid-19 epidemiologic and laboratory studies, further confirmed by subgroup analyses of the covid-19 randomized, controlled trials, that prior SARS-CoV-2 infection confers at least as robust, and more enduring and broad immunity to future SARS-CoV-2 infections, than vaccine-acquired immunity. [10-14] For example, locally, none of 423 unvaccinated Massachusetts healthcare workers with a prior SARS-CoV-2 infection were reinfected during 6-months plus of observation.  Finally, I analyzed RIDOH’s own data, provided to my state Representative Chippendale from January 2022 as the SARS-COV-2 omicron wave peaked in Rhode Island. Prior SARS-COV-2 infection, naturally acquired immunity, regardless of vaccination status, was associated with a 4-fold lower rate of new SARS-COV-2 infections, relative to full vaccination, with a history of prior infection.
Consider these vaccine trial comparisons. The 1954 polio trial of 1.8 million children  was ~780-fold larger than Pfizer’s randomized, controlled trial of ~2300 5-to-11 year-olds which garnered covid-19 vaccine approval in this age group.  Understand that during the first 9-months of 1953, alone, Rhode Island recorded 289 clinical, i.e., crippling, pediatric polio cases, with 15 deaths, a 5.2% fatality rate.  Over 2-years there have been zero pediatric covid-19 deaths in Rhode Island, despite thousands of so-called “cases.” For an order of magnitude more lethal and crippling childhood disease than covid-19, polio vaccination in the 1954 trial prevented 374 cases of paralytic polio. Despite recruiting 20% with comorbidities, Pfizer’s pediatric covid-19 vaccine trial recorded no cases of severe covid-19 in either group, but did “prevent” 13 cases of sniffles. Not even sniffles occurred in the covid-19 vaccine or placebo groups among children with a history of prior SARS-COV-2 infection. 
We must return, immediately, to rational, data-driven vaccine policies of the recent past, such as the Center For Diseases Control and Prevention (CDC)’s 2009-10 H1N1 swine flu pandemic vaccine guidelines. Per these guidelines, vaccinating potentially high-risk individuals was RECOMMENDED, NOT MANDATED, and also, naturally-acquired immunity, i.e., PCR-documented prior infection, was explicitly acknowledged as an alternative to vaccination. 
 “EVALUATION OF THE 1954 POLIOMYELITIS VACCINE FIELD TRIALFURTHER STUDIES OF RESULTS DETERMINING THE EFFECTIVENESS OF POLIOMYELITIS VACCINE (SALK) IN PREVENTING PARALYTIC POLIOMYELITIS” https://jamanetwork.com/journals/jama/article-abstract/301691
 “Experimental and Quasi-Experimental Designs for Research.” https://www.sfu.ca/~palys/Campbell&Stanley-1959-Exptl&QuasiExptlDesignsForResearch.pdf
 “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations” https://www.bmj.com/content/336/7650/924.long
 “Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine” https://pubmed.ncbi.nlm.nih.gov/33378609/
 “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” https://pubmed.ncbi.nlm.nih.gov/33301246/
 “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
 “A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129324/pdf/jhyg00018-0010.pdf
 “The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.” https://pubmed.ncbi.nlm.nih.gov/7966893/
 “Soviet Genetics and World Science—Lysenko and the Meaning of Heredity” https://ia801601.us.archive.org/4/items/in.ernet.dli.2015.52393/2015.52393.Soviet-Genetics-And-World-Science.pdf
 “How Likely is Reinfection Following Covid Recovery?” https://brownstone.org/articles/how-likely-is-reinfection-following-covid-recovery/
 “The Thin Gruel of Randomized, Controlled Trial Evidence Supporting Covid-19 Vaccine Boosters (and Their Mandated Use)” https://www.andrewbostom.org/2021/12/the-thin-gruel-of-randomized-controlled-trial-evidence-supporting-covid-19-vaccine-boosters-and-their-mandated-use/
 “The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine” https://www.acpjournals.org/doi/10.7326/M21-4130
 “Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study”
 “Continued Effectiveness of COVID-19 Vaccination among Urban Healthcare Workers during Delta Variant Predominance” https://doi.org/10.1101/2021.11.15.21265753
 Link to RIDOH January, 2022 raw data: https://www.andrewbostom.org/wp-content/uploads/2022/02/RIDOH-data-1.22.xlsx; Rhode Island population data, ages 19+ years old = 889,003 (per 2018 census data)
https://docs.google.com/spreadsheets/d/1c2QrNMz8pIbYEKzMJL7Uh2dtThOJa2j1sSMwiDo5Gz4/edit#gid=661880792; Vaccination data, as of 1/15/22, n=775,554: https://docs.google.com/spreadsheets/d/1c2QrNMz8pIbYEKzMJL7Uh2dtThOJa2j1sSMwiDo5Gz4/edit#gid=1196542126; Prior infection, as of 1/15/22, =85%; n=755,653: https://covidestim.org/us/RI
 “Pediatric polio in Rhode Island, reported by the Newport Daily News, December 16, 1953: 289 cases treated, 15 deaths reported, through October 31, 1953, a 5.2% fatality rate”
 “Questions & Answers: Vaccine Against 2009 H1N1 Influenza Virus” https://www.cdc.gov/h1n1flu/vaccination/public/vaccination_qa_pub.htm
Dr. Andrew Bostom, a Brown University credentialed epidemiologist, is a medical reporter for The Ocean State Current and adjunct scholar to the RI Center for Freedom & Properity.